HOW CRYOABLATION KILLS TUMOUR CELLS:
ICE CRYSTALS AND CELL DEATH

Cryoablation does not kill tumour cells through a single mechanism — it kills through multiple overlapping processes that operate at different temperatures and at different stages of the freeze-thaw cycle. Understanding these mechanisms explains why the refreeze cycle matters, why the outer margin of the ice ball must extend beyond the tumour, and why cryoablation may have systemic immune effects beyond the treated lesion.

“Nature kills cells with ice rarely and accidentally. Cryoablation kills them with ice deliberately, precisely, and through four simultaneous biological pathways.”

• Mechanism 1 — Intracellular Ice Crystal Formation

  At very rapid cooling rates (achieved at temperatures below -40°C), water inside the tumour cell freezes before it can exit through the cell membrane. The resulting intracellular ice crystals expand mechanically — puncturing organelle membranes, rupturing mitochondria and the nucleus, and physically destroying the cell from within. This direct mechanical destruction is the most rapid and complete killing mechanism in cryoablation.

• Mechanism 2 — Osmotic Dehydration and Protein Denaturation

  At slower cooling rates (in the outer zone of the ice ball), water migrates out of cells into the expanding extracellular ice phase before intracellular freezing occurs. The resulting intracellular dehydration concentrates electrolytes and proteins to lethal levels — denaturing essential enzymes and causing osmotic shrinkage. The refreeze cycle particularly exploits this mechanism, as cells that survived the first cycle through dehydration are then killed by intracellular ice in the second.

The cellular events during a standard two-cycle cryoablation protocol follow a predictable biological sequence — each phase serving a distinct tumour-killing purpose.

1. 1

   Rapid Freeze — Phase 1 (0 to -40°C and below)

   Rapid freezing at the probe interface (centre of the ice ball) causes intracellular ice crystal formation — mechanically destroying cells directly adjacent to the probe. This is the highest-certainty lethal zone. Temperature at the probe tip: -140 to -180°C; temperature at the ice ball margin: approximately -20°C.

2. 2

   Slow Propagation — Outer Ice Ball Zone (-20°C to -40°C)

   At slower cooling rates in the outer ice ball zone, extracellular ice forms first. Intracellular water migrates outward, concentrating cell contents to lethal ionic levels. Cells in this zone experience osmotic injury — many die during the thaw phase when these concentrated intracellular solutes cause irreversible membrane damage.

3. 3

   Passive Thaw — Vascular Injury and Delayed Death

   As the ice ball thaws, blood vessels within the ablation zone — damaged by freeze injury to the endothelial cells — thrombose. This vascular occlusion cuts off blood supply to the entire ablation zone, causing ischaemic necrosis in the following hours to days. Cells that survived the freeze itself die from ischaemia during the thaw.

4. 4

   Refreeze — Second Cycle Kills Survivors

   The second freeze cycle is critical. Cells that survived the first freeze (particularly in the outer zone) are now dehydrated and depleted — the second freeze causes intracellular ice formation in these previously surviving cells at a lower threshold temperature. Published data demonstrates significantly higher complete ablation rates with 2-cycle vs 1-cycle protocols.',

5. 5

   Inflammatory Response and Immune Activation

   In the hours and days after cryoablation, the necrotic tumour tissue releases danger signals, tumour antigens, and pro-inflammatory cytokines. This creates a local and potentially systemic immune activation — dendritic cells process released tumour antigens, potentially priming anti-tumour T-cell responses against residual disease elsewhere.

Beyond direct physical cell destruction, cryoablation may trigger systemic anti-tumour immune responses — a phenomenon studied under the term 'cryoimmunology'. This distinguishes cryoablation from heat-based ablation, which destroys tumour antigens through protein denaturation.

• Immunogenic Cell Death

  Cryoablation creates a zone of necrotic tumour tissue that preserves tumour cell membrane architecture and releases intact tumour antigens — a form of immunogenic cell death. Heat-based ablation (RFA, microwave) denatures proteins and destroys antigens, potentially reducing the immunogenic signal. Cryoablation's cold mechanism may be more immunostimulatory.

• Abscopal Effect — Remote Tumour Response

  Case reports and small series describe abscopal responses after cryoablation — reduction of untreated tumour sites distant from the ablation zone — attributed to systemic T-cell activation triggered by cryoablation-released antigens. This effect is amplified when cryoablation is combined with immune checkpoint inhibitors.

The certainty of tumour cell death varies with distance from the probe — understanding the temperature gradient informs how aggressively the ice ball margin must extend beyond the visible tumour boundary.

The quantitative parameters that define lethal cryoablation and guide clinical probe positioning.

• -40°CTemperature threshold for reliable intracellular ice formation and cell killBelow -40°C, lethal intracellular ice formation is essentially guaranteed — this temperature must be achieved throughout the tumour, not just at the probe tip.
• 5–10 mmRequired ice ball margin beyond the tumour edge for reliable ablationBecause the ice ball margin zone has only 50–80% cell kill certainty, the ablation zone must extend 5–10 mm beyond the visible tumour to ensure complete treatment.
• 2× > 1×Improvement in complete ablation rate: two freeze cycles vs onePublished comparative data consistently shows higher complete ablation and lower local recurrence rates with two-cycle vs single-cycle cryoablation protocols.

Continue exploring cryoablation — from the visible ice ball advantage to disease-specific evidence in kidney and prostate cancer.

Frequently Asked Questions About Cryoablation's Mechanism